IndraLab

Statements


USP10 activates FLT3. 6 / 6
| 6

reach
"Intriguingly, USP10 inhibition has been shown to promote oncoprotein FLT3 degradation, suggesting that USP10 could be considered as a potential pharmacological target for fighting FLT3- mutant AML disease [XREF_BIBR]."

reach
"USP10 inhibition leads to death of cells driven by active SYK or oncogenic FLT3 and potentiates the anti-leukemic effects of FLT3 inhibition in these cells."

reach
"A more recent study revealed that USP10, a deubiquitinating enzyme, is essential for the stabilization of FLT3 protein and inhibition of USP10 induces the degradation of FLT3/ITD, as well as FLT3/TKD, albeit to a lesser extent [42]."

reach
"Inhibition of USP10 induces degradation of oncogenic FLT3."

reach
"It was recently reported that inhibition of USP10 also induces degradation of FLT3/ITD [42]."

reach
"In addition, we show that USP10 inhibition potentiates the effects of FLT3 inhibition in cells driven by activated SYK."